07:23 AM EDT, 05/06/2024 (MT Newswires) -- BioNTech (BNTX) reported a Q1 loss Monday of 1.31 euros ($1.41) per diluted share, swinging from earnings of 2.05 euros per share a year earlier.

Analysts polled by Capital IQ expected a loss of 1.53 euros

Total revenue for the quarter ended March 31 was 187.6 million euros, down from 1.277 billion euros a year earlier.

Analysts polled by Capital IQ expected 372.3 million euros.

For 2024, the biotechnology company reiterated its financial outlook, saying its expects total revenue of 2.5 billion euros to 3.1 billion euros. Analysts surveyed by Capital IQ expect 2.79 billion euros.

BioNTech shares of were down more than 4% in recent premarket activity.

Price: 89.94, Change: -2.78, Percent Change: -3.00